Cargando…
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is a heterogeneous disease with various etiological factors, and ranks as the second leading cause of cancer-related mortality worldwide due to multi-focal recurrence. We herein identified three major subtypes of HCC by performing integrative analysis of tw...
Autores principales: | Shimada, Shu, Mogushi, Kaoru, Akiyama, Yoshimitsu, Furuyama, Takaki, Watanabe, Shuichi, Ogura, Toshiro, Ogawa, Kosuke, Ono, Hiroaki, Mitsunori, Yusuke, Ban, Daisuke, Kudo, Atsushi, Arii, Shigeki, Tanabe, Minoru, Wands, Jack R., Tanaka, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412165/ https://www.ncbi.nlm.nih.gov/pubmed/30598371 http://dx.doi.org/10.1016/j.ebiom.2018.12.058 |
Ejemplares similares
-
DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma
por: Mizuno, Yuki, et al.
Publicado: (2018) -
Proteasome activity is required for the initiation of precancerous pancreatic lesions
por: Furuyama, Takaki, et al.
Publicado: (2016) -
C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer
por: Ono, Hiroaki, et al.
Publicado: (2021) -
Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis
por: Ito, Hiromitsu, et al.
Publicado: (2016) -
Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells
por: Kato, Tomotaka, et al.
Publicado: (2021)